Genome Medical Announces Executive Changes
Genome Medical announced multiple board appointments and executive changes effective this month.
- Russell Glass, CEO of on-demand mental health company Ginger, will join its Board of Directors as an independent director.
- Marco Barella joins the firm as Chief Product Officer and has 20 years of experience turning innovative technologies into successful businesses with wide adoption, including artificial intelligence insights, SaaS, and mobile apps. He is passionate about transforming the health care industry and improving patient outcomes and most recently held strategic product positions at Tiatros and IBM Watson Health.
- Brandon Poe will join the company as Chief Financial Officer. He brings over 20 years of experience across various industries, including life sciences, medical devices, consumer electronics, and travel.
Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine. The startup provides telehealth genetic consultations.